| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 08/02/2007 | US20070179288 Triphosphate oligonucleotide modification reagents and uses thereof |
| 08/02/2007 | US20070179116 Fused Pentacyclic Polyethers |
| 08/02/2007 | US20070179115 Purinenucleoside derivative modified in 8-position and medical use thereof |
| 08/02/2007 | US20070179114 Novel 2'-C methyl nucleoside derivatives |
| 08/02/2007 | US20070179112 Polymeric nucleoside prodrugs |
| 08/02/2007 | US20070179100 Protected monomers |
| 08/02/2007 | US20070178487 Active-site engineering of nucleotidylyltransferases and general enzymatic methods for the synthesis of natural and "unnatural" udp- and tdp-nucleotide sugars |
| 08/02/2007 | CA2638837A1 Lna modified phosphorothiolated oligonucleotides |
| 08/01/2007 | EP1813623A1 Purinenucleoside derivative modified in 8-position and medicinal use thereof |
| 08/01/2007 | EP1813278A1 Nucleoside analogs with carboxamidine modified monocyclic base |
| 08/01/2007 | EP1812456A2 ß-L-N4-HYDROXYCYTOSINE DEOXYNUCLEOSIDES AND THEIR USE AS PHARMACEUTICAL AGENTS IN THE PROPHYLAXIS OR THERAPY OF VIRAL DISEASES |
| 08/01/2007 | EP1812454A2 Chemical synthesis of s-adenosyl-l-methionine with enrichment of (s,s)-isomer |
| 08/01/2007 | EP1546354A4 Analyte detection |
| 08/01/2007 | CN1329408C Phosphitylation process |
| 08/01/2007 | CN1329407C Method for synthesizing beta-L-5-fluoro-2',3'-dideoxy-2',3'-didehydrocytidine |
| 08/01/2007 | CN101010330A Partial and full agonists of A1 adenosine receptors |
| 08/01/2007 | CN101010329A Method for the preparation of 2'-deoxy-2',2'-difluoro cytidine |
| 08/01/2007 | CN101007830A Chemical synthesis method for producing 2'-dexoyadenosine |
| 07/31/2007 | US7250517 Luminescent compounds |
| 07/31/2007 | US7250416 Alkyl, substituted or unsubstituted ribose, or 2'-deoxyribose substituted 1,3,5-triazin-2(1H)-ones, which may be additionally substituted with alkyl, aryl, halo, amino, oxy, thio, and/or hydrazine groups; used for treating diseases such as hematological disorders and cancer |
| 07/26/2007 | WO2007083928A1 Dna chip for diagnosis of corneal dystrophy |
| 07/26/2007 | WO2007083631A1 Method of stabilizing s-adenosyl-l-methionine and stabilized composition |
| 07/26/2007 | WO2007060689A3 Process for the large scale production of stavudine |
| 07/26/2007 | WO2007053869A3 Novel 2,2-dithiosubstituted furanose derivatives, method for the production and use thereof |
| 07/26/2007 | US20070172925 Ribonucleic acid compound and method of liquid-phase synthesis of oligonucleic acid compound |
| 07/26/2007 | US20070172883 Comparative fluorescence hybridization to nucleic acid arrays |
| 07/26/2007 | US20070172869 Enzymatic nucleic acid synthesis: methods for inhibiting pyrophosphorolysis during sequencing synthesis |
| 07/26/2007 | US20070172860 Enzymatic nucleic acid synthesis: compositions and methods |
| 07/26/2007 | US20070172859 Enzymatic nucleic acid synthesis: methods for direct detection of tagged monomers |
| 07/26/2007 | US20070172849 Detection of markers in nascent proteins |
| 07/26/2007 | US20070172819 Enzymatic nucleic acid synthesis: compositions including pyrophosphorolysis inhibitors |
| 07/25/2007 | EP1809301A2 Preparation of 2'fluoro-2'-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives |
| 07/25/2007 | EP1537133B1 Partial and full agonists of a1 adenosine receptors |
| 07/25/2007 | EP1379536A4 Building blocks for the solution phase synthesis of oligonucleotides |
| 07/25/2007 | EP1287012B1 Nucleotide analogues comprising a reporter moiety and a polymerase enzyme blocking moiety |
| 07/24/2007 | US7247721 Materials and methods for binding nucleic acids to surfaces |
| 07/24/2007 | US7247720 Nucleosides was phosphitylated using O- beta -cyanoethyl-N,N,N',N'-tetraisopropylphosphoramidite and the N-methylimidazole salt of saccharin as activator |
| 07/24/2007 | US7247621 Antiviral phosphonate compounds and methods therefor |
| 07/24/2007 | CA2479846C Phosphonomethoxymethylpurine/pyrimidine derivatives |
| 07/24/2007 | CA2311476C Dibenzorhodamine dyes useful as florescent labelling agents |
| 07/19/2007 | WO2007081031A1 Glycosyltransferase inhibitor |
| 07/19/2007 | WO2005044836A3 Macromolecular nucleotide compounds and methods for using the same |
| 07/19/2007 | US20070167615 Macrocyclic oligonucleotide labeling reactants and conjugates derived thereof |
| 07/19/2007 | US20070167387 nucleosides or oligonucleotide analogues having excellent enzyme resistance and potent selective binding affinity for single-stranded RNA, and excellent triplex-forming capacity with double-stranded DNA |
| 07/19/2007 | US20070167383 Nucleoside compounds for treating viral infections |
| 07/19/2007 | US20070167353 Prodrug composition |
| 07/19/2007 | US20070166705 Invention relates to nucleotide or nucleoside molecules modified by reversible covalent attachment of 3'-OH blocking groups thereto, and which molecules may be used in reactions where blocked nucleotide or nucleoside molecules are required, such as in sequencing reactions, polynucleotide synthesis |
| 07/18/2007 | EP1807438A1 Beta-glucuronidase cleavable prodrugs of o6-alkylguanine-dna alkyltransferase inactivators |
| 07/18/2007 | EP1644392B1 Rapamycin carbohydrate derivatives |
| 07/18/2007 | CN101001865A Purine nucleotide derivatives |
| 07/18/2007 | CN101001864A Sequence-specific detection of methylation in biomolecules |
| 07/18/2007 | CN101001863A Tanaproget derivatives, metabolites, and uses thereof |
| 07/18/2007 | CN100999540A Tech, of producing cytidine by chemical synthesizing process |
| 07/17/2007 | US7244839 Corn starch comprising high concentration of amylose for use in animal feeds and medicines; dry-milling/wet-milling; paper and textile; adhesives; explosives; oil-well muds; mining |
| 07/17/2007 | US7244717 Mutagenic nucleoside analogs for the treatment of viral disease |
| 07/17/2007 | US7244716 Synergistic mixture of tipranavir and 3'-deoxy-3'-fluorothymidine, -cytosine, -adenosine, and/or guanosine type derivatives; human T-cell leukemia/lymphoma virus, lymphadenopathy associated virus; AIDS |
| 07/17/2007 | US7244713 7-(2'-C-methyl- beta -D-ribofuranosyl)-4-amino-5-(2'-trimethylsilylethyn-1-yl)-pyrrolo[2,3-d]pyrimidine; treating hepatitis C; viricide mixture contains other active drugs |
| 07/17/2007 | US7244585 Producing a recombinant or chimeric GBV-B virus by introducing into a host cell a genome composed of a 3' terminal sequence of GBV-B and culturing the host cell to produce the virus from the genome. |
| 07/12/2007 | WO2007058800A3 Phospholipid gel compositions for delivery of aptamers and methods of treating conditions using same |
| 07/12/2007 | WO2005027962A3 4’-thionucleosides and oligomeric compounds |
| 07/12/2007 | US20070161667 Process for preparing inhibitors of nucleoside metabolism |
| 07/12/2007 | US20070161602 Phosphonate compounds |
| 07/12/2007 | US20070161007 Synthetic cofactor analogs of S-adenosylmethionine as ligatable probes of biological methylation and methods for their use |
| 07/12/2007 | US20070160682 Reacting tris(trimethylsilyl)-phosphite with borane-dimethylsulfide complex, in dry acetonitrile under inert gas, and treating intermediate with suitable base in water or methanol; fertilizers, in detergent formulations, as additive in melts for glass industry, boron neutron-capture therapy of cancer |
| 07/12/2007 | US20070160554 Acyl ribonucleosides and acyl deoxyribonucleosides, compositions of, and methods of making same |
| 07/11/2007 | EP1806134A1 Agent and food for preventing/improving functional digestive disorder |
| 07/11/2007 | EP1805196A1 Substituted adenines and the use thereof |
| 07/11/2007 | EP1804812A2 Fluorinated pyrroloý2,3-d¨pyrimidine nucleosides for the treatment of rna-dependent rna viral infection |
| 07/11/2007 | EP1804811A2 Methods and compositions for treating flaviviruses, pestiviruses and hepacivirus |
| 07/11/2007 | CN1997658A Synthesis of protected 3'-amino nucleoside monomers |
| 07/11/2007 | CN1995057A Imidazoline salt, rhodium complex of carbohydrate derivative and its preparation method |
| 07/11/2007 | CN1995022A Process for the synthesis of nucleoside analogues |
| 07/11/2007 | CN1325057C Use of corrinoids in the treatment of skin diseases |
| 07/11/2007 | CN1325056C Chloasma amelioration composition and dullness amelioration composition |
| 07/10/2007 | US7241897 Process for preparing cyanine dye labeling reagents |
| 07/05/2007 | WO2007074213A1 Macrocyclic oligonucleotide labeling reactants and conjugates derived thereof |
| 07/04/2007 | EP1803729A1 1-( -d-glycopyranosyl)-3-substituted nitrogenous heterocyclic compound, medicinal composition containing the same, and medicinal use thereof |
| 07/04/2007 | EP1802635A2 Heteroatoms-containing tricyclic compounds |
| 07/04/2007 | EP1802316A2 Purine derivatives and methods of use thereof |
| 07/03/2007 | US7238795 Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses |
| 07/03/2007 | US7238792 Nucleotide sequences comprising flexible linkers and chromophore for use in diagnosis of cell prolifferative disorders |
| 07/03/2007 | US7238676 Purine derivatives |
| 07/03/2007 | US7238530 Contacting a mixture of single stranded mRNA and double stranded nucleic acid material with a liquid comprising a chaotropic agent and a nucleic acid binding solid phase, solid phase binds double-stranded nucleic acid, not single |
| 07/03/2007 | US7238338 Antioxidant, such as ethanol and/or ascorbic acid added to the radiolabeled compound during its preparation and/or storage, allows retention of biological or chemical activity of the radiohalogen-labeled compound such as nucleosides, nucleotides |
| 06/28/2007 | WO2007019221A3 Pharmaceutical compositions of silicon-containing substituted adenosine nucleoside amide analogs |
| 06/28/2007 | US20070149462 Nucleotide and oligonucleotide prodrugs |
| 06/28/2007 | US20070148680 Detection of disease related genes |
| 06/28/2007 | US20070148645 Nucleic acid sequencing methods, kits and reagents |
| 06/28/2007 | DE102005063244A1 Modifiziertes 2-Nitroimidazol-Derivat The modified 2-nitroimidazole derivative |
| 06/27/2007 | EP1799698A1 Bioreductively-activated prodrugs |
| 06/27/2007 | EP0851870B1 Colon cell and colon cancer cell associated nucleic acid molecules, protein and peptides |
| 06/26/2007 | US7235650 Having substituents such as steroids, reporter molecules/enzymes, non-aromatic lipophilic molecules, peptides, or proteins attached via linking groups; improved diagnosis |
| 06/26/2007 | US7235647 Intermediate and process for preparing of β- anomer enriched 21-deoxy,21,21-difluoro-D-ribofuranosyl nucleosides |
| 06/26/2007 | US7235535 Method of enhancing drainage of lacrimal system with purinergic receptor agonists |
| 06/26/2007 | CA2413037C Intermediates for producing antitumor indolopyrrolocarbazole derivatives |
| 06/26/2007 | CA2207617C Process for preparing 1-(2'-deoxy-2',2'-difluoro-d-ribofuranosyl-4-aminopyrimidin-2-one) hydrochloride |
| 06/21/2007 | WO2007070804A2 Process for preparing gemcitabine and associated intermediates |
| 06/21/2007 | WO2007068113A1 4'-thioarabinonucleotide-containing oligonucleotides, compounds and methods for their preparation and uses thereof |
| 06/21/2007 | US20070142310 treating Human Immuno-Deficiency Virus (HIV); nucleoside or nucleotide analogues; RNA viral diseases; anticarcinogenic agents treating hematopoetic cancers |
| 06/20/2007 | CN1984663A Effective treatment of tumors and cancer with triciribine and related compounds |